KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Construction in Progress (2015 - 2026)

Bristol Myers Squibb (BMY) reported Construction in Progress of $1.5 billion for Q1 2026, down 6.94% year-over-year from $1.7 billion in Q1 2025, and down 4.82% on a QoQ basis from $1.6 billion in Q4 2025.

Bristol Myers Squibb (BMY) has 12 years of Construction in Progress data on file, last reported at $1.5 billion in Q1 2026.

  • Quarterly Construction in Progress fell 6.94% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 6.94% YoY) and the FY2025 annual result came in at $1.6 billion, up 6.16% from the prior year.
  • Construction in Progress retreated to $1.5 billion in Q1 2026 per BMY's latest filing, from $1.6 billion in the prior quarter.
  • Across five years, Construction in Progress topped out at $1.8 billion in Q2 2025 and bottomed at $800.0 million in Q1 2022.
  • The 5-year median for Construction in Progress is $1.2 billion (2024), against an average of $1.3 billion.
  • The widest annual swing landed in 2022, when Construction in Progress jumped 54.14%; it then slipped 6.94% in 2026.
  • Tracing BMY's Construction in Progress over 5 years: stood at $1.1 billion in 2022, then advanced by 2.09% to $1.1 billion in 2023, then surged by 41.86% to $1.5 billion in 2024, then advanced by 6.16% to $1.6 billion in 2025, then dropped by 4.82% to $1.5 billion in 2026.
  • Per Business Quant, the three latest BMY Construction in Progress figures stand at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn -
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.54 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.54 Bn
Dec 31, 2025 1.62 Bn
Sep 30, 2025 1.46 Bn
Jun 30, 2025 1.76 Bn
Mar 31, 2025 1.66 Bn
Dec 31, 2024 1.53 Bn
Sep 30, 2024 1.37 Bn
Jun 30, 2024 1.26 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.08 Bn
Sep 30, 2023 1.11 Bn
Jun 30, 2023 1.20 Bn
Mar 31, 2023 1.07 Bn
Dec 31, 2022 1.05 Bn
Sep 30, 2022 973.00 Mn
Jun 30, 2022 850.00 Mn
Mar 31, 2022 800.00 Mn
Dec 31, 2021 764.00 Mn
Sep 30, 2021 695.00 Mn
Jun 30, 2021 565.00 Mn
Mar 31, 2021 519.00 Mn
Dec 31, 2020 487.00 Mn
Sep 30, 2020 409.00 Mn
Jun 30, 2020 422.00 Mn
Mar 31, 2020 456.00 Mn
Dec 31, 2019 527.00 Mn
Sep 30, 2019 465.00 Mn
Jun 30, 2019 453.00 Mn
Mar 31, 2019 477.00 Mn
Dec 31, 2018 548.00 Mn
Dec 31, 2017 980.00 Mn
Dec 31, 2016 849.00 Mn
Dec 31, 2015 662.00 Mn